Mascoma Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$682 Buy
+5
New +$614 ﹤0.01% 535
2019
Q3
Sell
-700
Closed -$60K 279
2019
Q2
$60K Hold
700
0.04% 149
2019
Q1
$41K Buy
+700
New +$40.3K 0.03% 164

Other funds holding RGEN

Mascoma Wealth Management's RGEN Position: Q2 2026 in Review

Mascoma Wealth Management opened a new position in Repligen (RGEN) in Q2 2026: 5 shares worth $682. The stake represents ﹤0.01% of the portfolio and ranks #535 among its holdings. This is a return to the name: Mascoma Wealth Management previously reported a position in RGEN as recently as Q2 2019.

Mascoma Wealth Management first reported a position in RGEN in Q1 2019 and has held it in 3 quarters since. The position peaked at $60K in Q2 2019. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Mascoma Wealth Management held 5 shares of Repligen worth $682 as of Q2 2026.
  • Repligen was a new Mascoma Wealth Management position in Q2 2026.
  • Repligen made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #535 holding.
  • Mascoma Wealth Management first reported a position in Repligen in Q1 2019 and has held it in 3 quarters since.
  • Mascoma Wealth Management's Repligen position peaked at $60K in Q2 2019.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.